-       Report 
- October 2025
-  381 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  478 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
            -       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €894EUR$1,000USD£787GBP 
      €1118EUR$1,250USD£983GBP 
          -       Report 
- August 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- August 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
           -       Report 
- August 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- November 2024
-  180 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
            -       Report 
- July 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
            -       Report 
- March 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
          -       Report 
- June 2025
-  195 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- March 2025
-  85 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- April 2025
-  195 Pages 
- Global 
   From       €4468EUR$4,995USD£3,930GBP 
            -       Report 
- March 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- June 2025
-  205 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
            -       Report 
- June 2025
-  160 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
            -       Report 
- June 2025
-  130 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
            -       Report 
- May 2025
-  160 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
            -       Report 
- May 2025
-  135 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
            -       Report 
- May 2025
-  140 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
       
      The Antiparasitic Agent market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs used to treat parasitic infections. Antiparasitic Agents are used to treat a variety of parasitic infections, including malaria, schistosomiasis, and leishmaniasis. These drugs are typically administered orally, intravenously, or topically, depending on the type of infection. Antiparasitic Agents are often used in combination with other drugs to ensure the most    effective treatment.
The Antiparasitic Agent market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novartis. Other companies, such as Johnson & Johnson, Bayer, and AstraZeneca, also offer Antiparasitic Agents. Show Less   Read more